These results indicated that rPR8-CCL19, by infecting CRC and expressing CCL19, not only significantly recruited T cells but also activated them, enabling T cells to express anti-tumor molecules that might enhance tumor cell death significantly. The gene discussed is CCL19; the disease is colorectal carcinoma.